Adam Silverman

Adam Silverman

Company: Codexis

Job title: Director of Therapeutics Discovery

Seminars:

Panel Discussion: Innovating ERT Modalities to Expand the Array of Options Available to Patients 10:00 am

Look back at what advancement have been made in the field and where the new opportunities could lie Analyze case studies of innovations that have been successful and unsuccessfulRead more

day: Day Two

Engineered Enzymes As Next-Generation ERTs 9:00 am

While enzyme replacement therapies (ERTs) help many patients with genetic disorders, the enzymes being replaced often have sub-optimal properties as drugs – poor stability in body fluids, low uptake in target cells and tissues, and high immunogenicity We describe our CodeEvolver® protein engineering platform that incorporates high-throughput screening, next-gen sequencing, and artificial intelligence to iteratively…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.